论文标题
自适应提示网络辅助神经胶质瘤诊断而没有对比增强的MRI
Adaptive PromptNet For Auxiliary Glioma Diagnosis without Contrast-Enhanced MRI
论文作者
论文摘要
多对比度磁共振成像(MRI)基于自动辅助神经胶质瘤诊断在诊所中起重要作用。在大多数现有的相关研究中,都使用了对比增强的MRI序列(例如,对比增强的T1加权成像),其中报道了显着的诊断结果。然而,由于患者的生理局限性,获取对比增强的MRI数据有时不可行。此外,在诊所收集对比度增强的MRI数据是更耗时且昂贵的。在本文中,我们提出了一个自适应提示网络来解决这些问题。具体而言,仅构建了仅利用非增强MRI数据的促胶质瘤分级的促进网络。提示网络通过设计及时损失在培训期间从对比度增强的MR数据的特征中获得限制。为了进一步提高性能,自适应策略旨在以基于样本的方式动态加权及时损失。结果,PressNet能够处理更困难的样本。在广泛使用的BRATS2020数据集上评估了我们方法的有效性,并在NE-MRI数据上进行了竞争性神经胶质瘤分级性能。
Multi-contrast magnetic resonance imaging (MRI)-based automatic auxiliary glioma diagnosis plays an important role in the clinic. Contrast-enhanced MRI sequences (e.g., contrast-enhanced T1-weighted imaging) were utilized in most of the existing relevant studies, in which remarkable diagnosis results have been reported. Nevertheless, acquiring contrast-enhanced MRI data is sometimes not feasible due to the patients physiological limitations. Furthermore, it is more time-consuming and costly to collect contrast-enhanced MRI data in the clinic. In this paper, we propose an adaptive PromptNet to address these issues. Specifically, a PromptNet for glioma grading utilizing only non-enhanced MRI data has been constructed. PromptNet receives constraints from features of contrast-enhanced MR data during training through a designed prompt loss. To further boost the performance, an adaptive strategy is designed to dynamically weight the prompt loss in a sample-based manner. As a result, PromptNet is capable of dealing with more difficult samples. The effectiveness of our method is evaluated on a widely-used BraTS2020 dataset, and competitive glioma grading performance on NE-MRI data is achieved.